Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.

BACKGROUND: The discovery of low-frequency coding variants affecting the risk of coronary artery disease has facilitated the identification of therapeutic targets. METHODS: Through DNA genotyping, we tested 54,003 coding-sequence variants covering 13,715 human genes in up to 72,868 patients with coronary artery disease and 120,770 controls who did not have coronary artery disease. Through DNA sequencing, we studied the effects of loss-of-function mutations in selected genes. RESULTS: We confirmed previously observed significant associations between coronary artery disease and low-frequency missense variants in the genes LPA and PCSK9. We also found significant associations between coronary artery disease and low-frequency missense variants in the genes SVEP1 (p.D2702G; minor-allele frequency, 3.60%; odds ratio for disease, 1.14; P=4.2×10(-10)) and ANGPTL4 (p.E40K; minor-allele frequency, 2.01%; odds ratio, 0.86; P=4.0×10(-8)), which encodes angiopoietin-like 4. Through sequencing of ANGPTL4, we identified 9 carriers of loss-of-function mutations among 6924 patients with myocardial infarction, as compared with 19 carriers among 6834 controls (odds ratio, 0.47; P=0.04); carriers of ANGPTL4 loss-of-function alleles had triglyceride levels that were 35% lower than the levels among persons who did not carry a loss-of-function allele (P=0.003). ANGPTL4 inhibits lipoprotein lipase; we therefore searched for mutations in LPL and identified a loss-of-function variant that was associated with an increased risk of coronary artery disease (p.D36N; minor-allele frequency, 1.9%; odds ratio, 1.13; P=2.0×10(-4)) and a gain-of-function variant that was associated with protection from coronary artery disease (p.S447*; minor-allele frequency, 9.9%; odds ratio, 0.94; P=2.5×10(-7)). CONCLUSIONS: We found that carriers of loss-of-function mutations in ANGPTL4 had triglyceride levels that were lower than those among noncarriers; these mutations were also associated with protection from coronary artery disease. (Funded by the National Institutes of Health and others.).Supported by a career development award from the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH) (K08HL114642 to Dr. Stitziel) and by the Foundation for Barnes–Jewish Hospital. Dr. Peloso is supported by the National Heart, Lung, and Blood Institute of the NIH (award number K01HL125751). Dr. Kathiresan is supported by a Research Scholar award from the Massachusetts General Hospital, the Donovan Family Foundation, grants from the NIH (R01HL107816 and R01HL127564), a grant from Fondation Leducq, and an investigator-initiated grant from Merck. Dr. Merlini was supported by a grant from the Italian Ministry of Health (RFPS-2007-3-644382). Drs. Ardissino and Marziliano were supported by Regione Emilia Romagna Area 1 Grants. Drs. Farrall and Watkins acknowledge the support of the Wellcome Trust core award (090532/Z/09/Z), the British Heart Foundation (BHF) Centre of Research Excellence. Dr. Schick is supported in part by a grant from the National Cancer Institute (R25CA094880). Dr. Goel acknowledges EU FP7 & Wellcome Trust Institutional strategic support fund. Dr. Deloukas’s work forms part of the research themes contributing to the translational research portfolio of Barts Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute for Health Research (NIHR). Drs. Webb and Samani are funded by the British Heart Foundation, and Dr. Samani is an NIHR Senior Investigator. Dr. Masca was supported by the NIHR Leicester Cardiovascular Biomedical Research Unit (BRU), and this work forms part of the portfolio of research supported by the BRU. Dr. Won was supported by a postdoctoral award from the American Heart Association (15POST23280019). Dr. McCarthy is a Wellcome Trust Senior Investigator (098381) and an NIHR Senior Investigator. Dr. Danesh is a British Heart Foundation Professor, European Research Council Senior Investigator, and NIHR Senior Investigator. Drs. Erdmann, Webb, Samani, and Schunkert are supported by the FP7 European Union project CVgenes@ target (261123) and the Fondation Leducq (CADgenomics, 12CVD02). Drs. Erdmann and Schunkert are also supported by the German Federal Ministry of Education and Research e:Med program (e:AtheroSysMed and sysINFLAME), and Deutsche Forschungsgemeinschaft cluster of excellence “Inflammation at Interfaces” and SFB 1123. Dr. Kessler received a DZHK Rotation Grant. The analysis was funded, in part, by a Programme Grant from the BHF (RG/14/5/30893 to Dr. Deloukas). Additional funding is listed in the Supplementary Appendix.This is the author accepted manuscript. The final version is available from the Massachusetts Medical Society via http://dx.doi.org/10.1056/NEJMoa150765

Mechanical and Swelling Properties of Copolyurethanes based on Hydroxy-Terminated Polybutadiene and its hydrogenated analog

Copolyurethane networks based on Hydroxy-Terminated Polybutadiene (HTPB) and Hydrogenated HTPB (HHTPB) have been synthesized using toluene diisocyanate as curing agent. Addition of HHTPB results in enhancement of properties, such as tensile strength and modulus, at nearly the same elongation values. It is possible to generate urethane networks with similar modulus and tensile strength with widely varying elongation values and vice versa by jointly altering the comonomer ratio, and the r (NCO/OH equivalent ratio) value. Dynamic mechanical studies have been made to determine the storage and loss moduli, and their variations with temperature. Solid propellant formulations processed with the copolyurethanes have been characterized for their mechanical strengths and burn rates

Mechanical and swelling properties of HTPB-based copolyurethane networks

Copolyurethanes of hydroxy terminated polybutadiene (HTPB) and ISRO–Polyol (ISPO), an indigenously developed castor-oil based polyol, have been prepared using toluene diiso-cyanate and hexamethylenediisocyanate. The mechanical strength and swelling characteristics of the copolyurethanes cured with trimethylol propane and triethanolamine have been studied to evolve improved solid propellant binders. By varying the ratios of the two hydroxy pre-polymers, chain extenders, and crosslinkers, copolyurethanes having a wide range of tensile strength and elongation could be obtained. Many of these systems are desirable for their use as propellant binders. The results have been explained in terms of the measured crosslink densities and other swelling properties. © 1993 John Wiley & Sons, Inc

Kinetics of copolyurethane network formation

Cure kinetics for the formation of copolyurethane networks of various compositions based on hydroxy-terminated polybutadiene(HTPB), poly(12-hydroxy stearic acid-co-TMP) ester polyol(PEP), and different isocyanates has been studied through viscosity build up during the cure reaction. The viscosity (N)-time (t) plots conform to the equation N = ae(bt), where a and b are empirical constants, dependent on the composition and the nature of the polyols and the isocyanates. The rate constants (b) for viscosity build up, evaluated from the slopes of dN/dt versus N plots at different temperatures, were found to vary significantly from 0.0073 to 0.25 min(-1); and the activation energies for gelation were found to be in the range 20 to 40 kJ mol(-1). The results have been interpreted in terms of the dependence of the rate constants on structural characteristics of the prepolymers. (C) 1997 John Wiley & Sons, Inc

Thermal decomposition studies on copolyurethanes based on hydroxyl terminated polybutadiene and poly(12-hydroxy stearic acid-co-TMP) ester polyol

Thermal degradation of copolyurethanes based on hydroxyl terminated polybutadiene (HTPB) and poly(12-hydroxy stearic acid-co-TMP) ester polyol (PEP) with varying compositions has been studied by thermo-gravimetric and pyrolysis-GC techniques. The copolyurethanes were found to decompose in multiple stages and the kinetic parameters were found to be dependent on the method of their evaluation. The activation energy for the initial stage of decomposition was found to increase, and for the main stage decreases with the increase in PEP content. The pyrolysis-GC studies on the ammonium perchlorate filled copolyurethanes (solid propellants) showed that the major products during the pyrolysis were C-2, C-3 hydrocarbons and butadiene. The amount of C-2 fraction in the pyrolyslate increased with solid loading, as well as with the HTPB content in the copolyurethanes. A linear relationship apparently exists between the amount of C-2 fraction and the burn rates of the solid propellants. (C) 2000 Elsevier Science Ltd. All rights reserved

Modeling of Polyurethane Networks Based on Hydroxy- Terminated Polybutadiene and Poly( 12-hydroxy stearic acid-co-TMP) Ester Polyol: Correlation of Network Parameters with Mechanical Properties

The modeling of network properties of copolyurethane systems of varying compositions based on hydroxy-terminated polybutadiene and poly(12-hydroxy stearic acid-co-TMP) ester polyol (PEP), a copolyester polyol derived from 12-hydroxy stearic acid and trimethylol propane, crosslinked by different triols, and cured by various isocyanate compounds, has been carried out by the alpha-model developed by Marsh et al. The network parameters such as crosslink density, effective chain length, sol content, and mechanical properties of these systems have been evaluated. The functionality distribution of PEP has been derived from Si-29 nuclear magnetic resonance spectroscopy of the silyl derivative of PEP and chemical analysis. The extent of cure reaction (p) has been estimated by the use of an empirical relationship of the type: p = a - b(A(3) x F-s), where A(3) is the mole fraction of the trifunctional component of the OH group and F-s is the fraction of secondary hydroxyls in the system. A method for evaluating the constants a and b is presented. The calculated network parameters by the alpha-model are found to be in good agreement with the observed values. Excellent linear correlations between the calculated network parameters and the mechanical properties of the urethane elastomers confirm the utility of the approach presented here in arriving at formulations with desired properties

Studies on urethane-allophanate networks based on hydroxyl-terminated polybutadiene: Modeling of network parameters and correlation to mechanical properties

10.1002/app.23541Journal of Applied Polymer Science10152986-2994JAPN